GT Biopharma Overview
GT Biopharma Discounted Cash Flow
DCF Analysis for GTBP.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.24
Current Fair Value
$1.24
↑ 140.4% Upside
Undervalued by 140.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison